Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Lung, Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00632203
What this trial is testing

Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)

Who this might be right for
Carcinoma, Non-Small-Cell LungAdenocarcinomaCarcinoma, Large Cell+1 more
Merck Sharp & Dohme LLC 53
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Ended earlyNCT00117351
What this trial is testing

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

Who this might be right for
Carcinoma, Non-Small-Cell LungAdenocarcinoma, Bronchiolo-Alveolar
Millennium Pharmaceuticals, Inc.
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Post-approval studies (Phase 4)UnknownNCT02103257
What this trial is testing

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Who this might be right for
EGFR Positive Non-small Cell Lung CancerAdenocarcinoma
Betta Pharmaceuticals Co., Ltd. 192
Testing effectiveness (Phase 2)Study completedNCT00077311
What this trial is testing

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
AnemiaDrug/Agent Toxicity by Tissue/OrganLung Cancer+1 more
Alliance for Clinical Trials in Oncology 160
Testing effectiveness (Phase 2)Study completedNCT03076164
What this trial is testing

A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib

Who this might be right for
Lung AdenocarcinomaLung CancerLung Cancer Metastatic+3 more
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00029003
What this trial is testing

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Bronchoalveolar Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 90
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Not applicableStudy completedNCT00900172
What this trial is testing

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 180
Testing effectiveness (Phase 2)Study completedNCT00816868
What this trial is testing

A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 62
Testing effectiveness (Phase 2)UnknownNCT00075517
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicableStudy completedNCT00897533
What this trial is testing

Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 137
Testing effectiveness (Phase 2)Study completedNCT03345810
What this trial is testing

Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)

Who this might be right for
Carcinoma, Non-Small-Cell LungMetastatic Lung CancerNon Small Cell Lung Cancer+2 more
AIO-Studien-gGmbH 200
Early research (Phase 1)Study completedNCT01302808
What this trial is testing

Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
University of Texas Southwestern Medical Center 17
Not applicableEnded earlyNCT00896467
What this trial is testing

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy

Who this might be right for
Anal CancerAnxiety DisorderBreast Cancer+9 more
Centre Oscar Lambret 200
Testing effectiveness (Phase 2)Looking for participantsNCT05503667
What this trial is testing

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China 96
Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04929041
What this trial is testing

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaLung Non-Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 427
Next Page